According to Aeterna Zentaris's latest financial reports the company's current EPS (TTM) is -$4.66. In 2022 the company made an earnings per share (EPS) of -$4.67 a decrease over its 2021 EPS that were of -$1.96.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$4.66 | -0.21% |
2022 | -$4.67 | 138.27% |
2021 | -$1.96 | -48.05% |
2020 | -$3.77 | -56.88% |
2019 | -$8.75 | -240% |
2018 | $6.25 | -122.94% |
2017 | -$27.25 | -54.96% |
2016 | -$60.50 | -93.07% |
2015 | -$872.72 | 20.13% |
2014 | -$726.50 | -225.69% |
2013 | $578.00 | -122.24% |
2012 | -$2,599 | -42.55% |
2011 | -$4,525 | -12.98% |
2010 | -$5,200 | -17.46% |
2009 | -$6,300 | -62.5% |
2008 | -$16,800 | 83.66% |
2007 | -$9,147 | -227.16% |
2006 | $7,194 | 105.81% |
2005 | $3,495 | -334.56% |
2004 | -$1,490 | -79.94% |
2003 | -$7,430 | 13.5% |
2002 | -$6,546 | 604.55% |
2001 | -$929.10 |
Company | EPS | EPS differencediff. | Country |
---|---|---|---|
Novartis NVS | $3.74 | -180.26% | ๐จ๐ญ Switzerland |
Sanofi SNY | $3.18 | -168.25% | ๐ซ๐ท France |
Bristol-Myers Squibb BMY | $3.97 | -185.19% | ๐บ๐ธ USA |
Spectrum Pharmaceuticals
SPPI | -$0.36 | -92.27% | ๐บ๐ธ USA |
Halozyme Therapeutics HALO | $1.74 | -137.34% | ๐บ๐ธ USA |